Validation of a commercially available SARS-CoV-2 serological immunoassay

Autor: Giulia Torriani, Hervé Spechbach, Nicolas Vuilleumier, Sabine Yerly, Lena Mazza, Laurent Kaiser, Gert Zimmer, Isabelle Arm-Vernez, Lionel Fontao, Idris Guessous, Jérôme Stirnemann, Claire-Anne Siegrist, Benjamin Meyer, Jérôme Pugin, Isabella Eckerle, Thomas Agoritsas, Adrien Calame, Pascale Roux-Lombard, Silvia Stringhini

Publikováno v: Meyer, Benjamin; Torriani, Giulia; Yerly, Sabine; Mazza, Lena; Calame, Adrien; Arm-Vernez, Isabelle; Zimmer, Gert; Agoritsas, Thomas; Stirnemann, Jérôme; Spechbach, Hervé; Guessous, Idris; Stringhini, Silvia; Pugin, Jérôme; Roux-Lombard, Pascale; Fontao, Lionel; Siegrist, Claire-Anne; Eckerle, Isabella; Vuilleumier, Nicolas; Kaiser, Laurent (2020). Validation of a commercially available SARS-CoV-2 serological immunoassay. Clinical microbiology and infection, 26(10), pp. 1386-1394. Elsevier 10.1016/j.cmi.2020.06.024
Clinical Microbiology and Infection
Clinical Microbiology and Infection (2020)

ObjectivesTo validate the diagnostic accuracy of a Euroimmun SARS-CoV-2 IgG and IgA immunoassay for COVID-19.MethodsIn this unmatched (1:1) case-control validation study, we used sera of 181 laboratory-confirmed SARS-CoV-2 cases and 176 controls coll

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1127cfecd2ecfe7c54c2856e996169c4
https://boris.unibe.ch/145436/1/b145436.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.